LuậnP.V., TùngN. Đình, HảiN.M. and TiếnN. Đạo 2024. Compare the effectiveness of afatinib and gefitinib as first-line treatment in patients with advanced stage non-small cell lung cancer haboring common EGFR mutations: Real-world data on PFS. Tạp chí Y Dược lâm sàng 108. 19, 5 (Sep. 2024). DOI:https://doi.org/10.52389/ydls.v19i5.2265.